Physical mapping of a tandem duplication on the long arm of chromosome 7 associated with a multidrug resistant phenotype

Cancer Genetics and Cytogenetics

Volumn 110, Issue 1, 1999, Pages 28-33

  De Silva, Michelle G ^a   Kantharidis, Phillip ^a   Scherer, Stephen W ^b   Rayeroux, Kathleen ^c   Campbell, Lynda ^c   Tsui, Lap Chee ^b   Zalcberg, John R ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P;

ARTICLE; CHROMOSOME 7P; CHROMOSOME DUPLICATION; CHROMOSOME MAP; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 7; DRUG RESISTANCE, MULTIPLE; HUMANS; LEUKEMIA, T-CELL; P-GLYCOPROTEIN; PHENOTYPE; PHYSICAL CHROMOSOME MAPPING; TUMOR CELLS, CULTURED;

EID: 0032922156     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00195-2     Document Type: Article

References (31)

1. Musto P., Melillo L., Lombardi G., Matera R., di Georgio G., Carotenuto M. High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission. Br J Haematol. 77:1991;50-53.
2. Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood. 79:1992;473-476.
3. Goasguen J.E., Dossot J.M., Fardel O., Le Mee F., Le Gall E., Leblay R., LePrise P.Y., Chaperon J., Fauchet R. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia. prognostic implications Blood. 81:1993;2394-2398.
4. Sauerbrey A., Zintl F., Volm M. P-Glycoprotein and glutathione S-transferase in childhood acute lymphoblastic leukemia. Br J Cancer. 70:1994;1144-1149.
5. Guerci A., Merlin J.L., Missoum N., Feldmann L., Marchal S., Witz F., Rose C., Guerci O. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood. 85:1995;2147-2153.
6. Samdani A., Vijapurkar U., Grimm M.A., Spier C.S., Grogan T.M., Glinsmann-Gibson B.J., List A.F. Cytogenetics and p-glycoprotein (Pgp) are independent predictors of treatment outcome in acute myeloid leukemia (AML). Leuk Res. 20:1996;175-180.
7. Trent J.M., Callen D.F. Chromosome localization of P-glycoprotein genes in drug-sensitive and -resistant human cells. Roninson I.B. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. 1991;169-188 Plenum Press, New York.
8. + acute myeloid leukemia cells. Blood. 82:1993;3157-3162.
9. Del Poeta G., Stasi R., Aronica G., Venditti A., Cox M.C., Bruno A., Buccisano F., Masi M., Tribalto M., Amadori S., Papa G. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood. 87:1996;1997-2004.
10. Fourth International Workshop on Chromosomes in Leukemia, 1982 (1984): Abnormalities of chromosome 7 resulting in monosomy 7 or in deletion of the long arm (7q-): review of translocations, breakpoints, and associated abnormalities. Cancer Genet Cytogenet 11:300-303.
11. Velloso E.R.P., Micaux L., Ferrant A., Hernandez J.M., Meeus P., Dierlamm J., Criel A., Louwagie A., Verhoef G., Boogaerts M., Michaux J.L., Bosly A., Mecucci C., Van den Berghe H. Deletions of the long arm of chromosome 7 in myeloid disorders. loss of band 7q32 implies worst prognosis Br J Haematol. 92:1996;574-581.
12. Slovak M.L., Hoeltge G.A., Trent J.M. Cytogenetic alterations associated with the acquisition of doxorubicin resistance. possible significance of chromosome 7 alterations Cancer Res. 47:1987;6646-6652.
13. Nieuwint A.W.M., Baas F., Wiegant J., Joenje H. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines. Cancer Res. 52:1992;4361-4371.
14. Ganapathi R., Hoeltge G., Casey G., Grabowski D., Neelon R., Ford J. Acquisition of doxorubicin resistance in human leukemia HL-60 cells is reproducible associated with 7q21 chromosomal anomalies. Cancer Genet Cytogenet. 86:1996;116-119.
15. de Silva M., Kantharidis P., Wall D.M., Campbell L., Vrazas V., Nadalin G., Kaczmarczyk S.J., Hu X.F., Parkin J.D., Zalcberg J.R. Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids. Br J Cancer. 73:1996;169-174.
16. Zalcberg J.R., Hu X.F., Wall D.M., Mirski S., Cole S., Nadalin G., De Luise M., Parkin J.D., Vrazas V., Campbell L., Kantharidis P. Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line. Int J Cancer. 57:1994;1-7.
17. Kantharidis P., El-Osta A., deSilva M., Wall D.M.P., Hu X.F., Slater A., Nadalin G., Parkin J.D., Zalcberg J.R. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. Clin Cancer Res. 3:1997;2025-2032.
18. Foley G.E., Lazarus H., Farber S., Uzman B.G., Boone B.A., McCarthy R.E. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 18:1965;522-529.
19. Webber L.M., Garson O.M. Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet Cytogenet. 26:1983;123-132.
20. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
21. Heng H.H.Q., Tsui L.-C. FISH detection on DAPI-banded chromosomes. Choo K.H.A. In Situ Hybridization Protocols, Vol. 33: Methods in Molecular Biology. 1994;35-49 Humana Press, Totowa.
22. Moir D.T., Smith D.R. Large-insert cloning and analysis. Dracopoli N.C., Haines J.L., Korf B.R., Moir D.T., Morton C.C., Seidman C.E., Seidman J.G., Smith D.R. Current Protocols in Human Genetics, Vol. 1. 1994;5 Wiley-Liss, New York. 9.23-5.9.24.
23. Scherer S.W., Tompkins B.J.F., Tsui L.-C. A human chromosome 7-specific genomic DNA library in yeast artificial chromosomes. Mamm Genome. 3:1992;179-181.
24. Gogineni S.K., Elizaide A., Sanchez M.A., Verma R.S. Characterization of 7q- by FISH technique of a case with acute myelogenous leukemia evolving from agnogenic myeloid metaplasia. Leuk Res. 19:1995;481-483.
25. Hindkjaer J., Hammoudah S., Clausen N., Koch J., Pedersen B. Partial triplication (7q) in a child with acute lymphoblastic leukemia demonstrated with conventional cytogenetics, PRINS, and chromosome painting. Cancer Genet Cytogenet. 84:1995;19-23.
26. Tosi S., Harbott J., Haas O.A., Douglas A., Hughes D.M., Ross F.M., Biondi A., Scherer S.W., Kearney L. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH). Leukemia. 10:1996;644-649.
27. Pedersen B., Ellegaard J. A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression. Cancer Genet Cytogenet. 78:1994;181-188.
28. Ishwad C.S., Ferrell R.E., Davare J., Meloni A.M., Sandberg A.A., Surti U. Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas. Genes Chromosom Cancer. 14:1995;51-55.
29. Takahashi S., Shan A.L., Ritland S.R., Delacey K.A., Bostwick D.G., Liebe M.M., Thibodeau S.N., Jenkins R.B. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res. 55:1995;4114-4119.
30. Achille A., Biasi M.O., Zamboni G., Bogina G., Magalini A.R., Pederzoli P., Perucho M., Scarpa A. Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res. 56:1996;3808-3813.
31. Koike M., Takeuchi S., Yokota J., Park S., Hatta Y., Miller C.W., Tsuruoka N., Koeffler H.P. Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer. Genes Chromosom Cancer. 19:1997;1-5.